EAY has received travel support from Bristol-Myers Squibb and consulted with Lundbeck. TWF has received research support from and has consulted with Shire. RLF receives or has received research support, acted as a consultant and/or served on a speakers bureau for Abbott, Addrenex, AstraZeneca, Biovail, Bristol-Myers Squibb, Eli Lilly & Co., Forest, GlaxoSmithKline, Johnson & Johnson, KemPharm, Lundbeck, Neuropharm, Novartis, Noven, Organon, Otsuka, Pfizer, Sanofi-aventis, Seaside, Sepracore, Shire, Solvay, Supernus Pharmaceuticals, Validus, and Wyeth. GPA, AJF, and JKY have no conflicts of interest to disclose.
Suicidality in pediatric bipolar disorder: predictor or outcome of family processes and mixed mood presentation?
Article first published online: 14 FEB 2011
© 2011 John Wiley and Sons A/S
Volume 13, Issue 1, pages 76–86, February 2011
How to Cite
Algorta, G. P., Youngstrom, E. A., Frazier, T. W., Freeman, A. J., Youngstrom, J. K. and Findling, R. L. (2011), Suicidality in pediatric bipolar disorder: predictor or outcome of family processes and mixed mood presentation?. Bipolar Disorders, 13: 76–86. doi: 10.1111/j.1399-5618.2010.00886.x
- Issue published online: 14 FEB 2011
- Article first published online: 14 FEB 2011
- Received 22 February 2010, revised and accepted for publication 3 December 2010
Options for accessing this content:
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!